INS and obesity due to melanocortin 4 receptor deficiency: We addressed these issues by including body mass as a covariate in the statistical analyses for body‐size–dependent bone outcome variables (ie, cortical geometry and biomechanical properties) as recommended by Jepsen and colleagues.39 Similarly, obesity might affect blood flow through mechanisms unrelated to insulin resistance and T2D.